Established in 2001, StemLife Berhad (“StemLife” or the “Company”) is Malaysia’s pioneer private stem cell bank. The Company is a subsidiary of Cordlife Group Limited (“Cordlife”, together with its subsidiaries, the “Group”), a Singapore Exchange-listed company that operates the largest network of stem cell banks in Asia and has earned the trust of over 600,000 parents. 

StemLife and the Group have facilitated cord blood releases to 18 healthcare institutions across 10 countries, supporting stem cell transplants and cellular therapies. StemLife is committed to ensuring that their clients can use their cord blood anywhere in the world by obtaining a licence from the Malaysian Ministry of Health and accreditation from the AABB, a global leader in establishing patient safety standards for blood banking, transfusion medicine, blood management, and cellular therapies. Beyond cord blood banking, StemLife offers cryopreservation services for cord lining, cord tissue, and umbilical cord mesenchymal stem cells, along with stem cell expansion through collaboration with a cGMP laboratory. 

The Company also provides various diagnostic services, including non-invasive prenatal testing (NIPT), chromosomal microarray analysis, newborn metabolic screening and talent genetic screening. For more information, please visit www.stemlife.com.